Abstract
AIMS/OBJECTIVE: Conflicting data regarding cardiovascular effects of thiazolidinediones (TZDs) and extra-skeletal effects of vitamin D supported the need for a definitive trial. The Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) trial aimed to assess the effects of TZDs (rosiglitazone and pioglitazone) on cardiovascular outcomes and the effects of vitamin D (cholecalciferol) on cancers and mortality.
| Original language | English |
|---|---|
| Journal | Diabetologia |
| Volume | 55 |
| Issue number | 1 |
| Pages (from-to) | 36-45 |
| Number of pages | 10 |
| ISSN | 0012-186X |
| DOIs | |
| Publication status | Published - Jan 2012 |
Keywords
- Aged
- Cardiovascular Diseases
- Cholecalciferol
- Combined Modality Therapy
- Diabetes Mellitus, Type 2
- Dietary Supplements
- Dose-Response Relationship, Drug
- Double-Blind Method
- Early Termination of Clinical Trials
- Female
- Humans
- Hypoglycemic Agents
- Incidence
- Male
- Middle Aged
- Neoplasms
- Risk Factors
- Thiazolidinediones
Fingerprint
Dive into the research topics of 'Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS